Green Cures & Botanical Distribution Inc (GRCU) 0.0148

New Post Public Reply Private Reply Replies (0) Message Board

Jun 4, 2016 at 12:18 AM

Green Cures & Botanical Distribution Inc (GRCU) 0.0148 $GRCU

MRNJ, Metatron Inc. Announces Cannabis Investment Firm Pacific Equity Alliance LLC
ACCESSWIRE - Fri Apr 22, 8:30AM CDT
DOVER, DE / ACCESSWIRE / April 22, 2016 / Pacific Equity Alliance LLC has been retained by Metatron Inc. (OTCPink: MRNJ) to preform corporate consulting services over a one year period in 2016 into 2017. Pacific Equity is the leading Institution for market awareness & investor support in North America located in Southern California.

Icon Beverages And Hollywood Hemp In 420 Week Strengthened By Peak Interest Of Celebrities, Icons, Presidents And Vox Populi
PR Newswire - Thu Apr 21, 8:00AM CDT
Green Cures & Botanical Distribution Inc. (OTC:GRCU) wants consumers to know the meaning behind "420" and its impact on GRCU and its creation of its hemp based product lines. 420 Week may have been started by an obscure group on a college campus in 1971 who celebrated cannabis culture, but now, 45 years later, icons and celebrities around the globe along with millions in the lifestyles celebrate 420.

Green Cures & Botanical Distribution Inc. (GRCU) announces appointment of renowned entrepreneur and product developer, Michael Lajtay to its management team
PR Newswire - Wed Apr 13, 8:00AM CDT
Green Cures and Botanical Distribution Inc. (OTC: GRCU) today announced the appointment of renowned entrepreneur and beverage developer Mr. Michael Lajtay (pronounced "Lay-tay"

to its management team as COO, President and lead product developer.

Green Cures & Botanical Distribution Announces Hemp Inc
ACCESSWIRE - Mon Mar 28, 9:21AM CDT
INGLEWOOD, CA / ACCESSWIRE / March 28, 2016 / Green Cures & Botanical Distribution Inc. (OTC PINK: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator announced today a signed consultant agreement with Hemp, Inc.'s (OTC PINK: HEMP) a wholly owned subsidiary of The Industrial Hemp and Medical Marijuana Consulting Company, Inc. (IHMMCC).

Green Cures & Botanical Distribution Announces Consulting Firm and Allhemp.Com
ACCESSWIRE - Tue Mar 22, 8:01AM CDT
WHITTIER, CA / ACCESSWIRE / March 22, 2016 / Green Cures & Botanical Distribution Inc. (OTC PINK: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator announced today Pacific Equity Alliance LLC has been retained by Green Cures & Botanical Distribution Inc. "GRCU" to preform corporate consulting services over a one year period in 2016. Pacific Equity, administrates corporate services for investor exposure and shareholder communication in addition to other services.

Green Cures Announces Allcbd.com and the Addition of New Products
ACCESSWIRE - Mon Nov 09, 8:00AM CST
WHITTIER, CA / ACCESSWIRE / November 9, 2015 / Green Cures & Botanical Distribution Inc. (PINKSHEETS: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator announced today that the newly redesigned www.allcbd.com website is fully operational and is currently processing orders from customers across the United States. Additionally, Green Cures is excited to announce the addition of new products and the availability of CBD Capsules, Vaporizers, and CBD Ointments through its e-commerce platform.

Green Cures & Botanical Distribution Announces Jimi Hendrix Icon Beverages
ACCESSWIRE - Tue Oct 20, 8:50AM CDT
WHITTIER, CA / ACCESSWIRE / October 20, 2015 / Green Cures & Botanical Distribution Inc. (PINKSHEETS: GRCU) ("Green Cures"

, InStep Holdings LLC through Green Cures & Botanical Distribution Inc. announces today a joint venture agreement with LaRoda LTD to introduce a variety of premium gourmet ready-to-drink (RTD) iced coffees and specialty bottled teas inspired by the legendary iconic guitarist, Jimi Hendrix's original Hand Painted Artwork.

Green Cures & Botanical Distribution Announces Executive Management Team
ACCESSWIRE - Tue Oct 06, 8:28AM CDT
WINNETKA, CA / ACCESSWIRE / October 6, 2015 / Green Cures & Botanical Distribution Inc. (OTC PINK: GRCU) ("Green Cures"

, Green Cures announces today the official appointment of Joe Tragesser as the company's Chief Executive Officer. Joe brings with him more than three decades of world-class consumer products experience. GRCU has also appointed Aymar Yoboue as the company's Chief Financial Officer. Aymar has 13 years of professional financial domestic and international experience with investment banks, industrial and technology companies.

Green Cures & Botanical Distribution Inc. Provides Corporate Update
ACCESSWIRE - Tue Sep 29, 9:01AM CDT
WINNETKA, CA / ACCESSWIRE / September 29, 2015 / Green Cures & Botanical Distribution Inc. (PINKSHEETS: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator is pleased to announce the following corporate update:

Green Cures Announces Reduction of Authorized Shares
ACCESSWIRE - Fri Aug 21, 7:45AM CDT
WINNETKA, CA / ACCESSWIRE / August 21, 2015 / Green Cures & Botanical Distribution Inc. (PINKSHEETS: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator, announced today the company has completed and filed a reduction in authorized common stock by 300,000,000 (three hundred million). In addition, the company announced that it has uploaded the second quarter financials for the period ended June 30 2015, to the OTC Markets Website.

Green Cures & Botanical Distribution Inc. announces Rico Suave Energy now available on Amazon.com
PR Newswire - Mon Mar 23, 7:11AM CDT
Green Cures & Botanical Distribution Inc. (OTC Pink: GRCU) ("Green Cures"

, a cannabis and industrial hemp products innovator, announced today that Rico Suave Energy drink/supplement infused with hemp is now available for purchase through www.amazon.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...